Using heart biomarker levels to guide therapy does not improve outcomes for heart failure patients

Using a measure of the hormone N-terminal brain natriuretic peptide (BNP) to guide therapy for older patients with heart failure did not improve overall clinical or quality of life outcomes compared to patients receiving conventional symptom-guided therapy, according to a study in the 28 January issue of JAMA...

Read the whole article on

More from